tiprankstipranks
Royalty Pharma PLC (RPRX)
NASDAQ:RPRX

Royalty Pharma (RPRX) Cash flow

673 Followers

Royalty Pharma Cash Flow

RPRX's free cash flow for Q4 2023 was $772.63M. For the 2023 fiscal year, RPRX's free cash flow was decreased by $673.68M and operating cash flow was $772.63M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Operating Cash Flow
$ 2.90B$ 2.99B$ 2.14B$ 2.02B$ 2.03B$ 1.67B
Investing Cash Flow
$ -2.07B$ -2.07B$ -1.03B$ -1.87B$ -2.76B$ -2.15B
Financing Cash Flow
$ -2.15B$ -2.15B$ -944.86M$ 385.11M$ 1.49B$ -1.19B
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
$ 5.56B$ 477.01M$ 1.71B$ 1.54B$ 1.01B$ 246.20M
Income Tax Paid Supplemental Data
------
Interest Paid Supplemental Data
$ -169.17M$ -169.17M$ -170.14M$ -130.43M--
Issuance Of Capital Stock
----$ 1.91B$ 0.00
Issuance Of Debt
$ -1.00B$ -1.00B$ -1.35M$ 1.27B$ 11.89B$ 0.00
Repayment Of Debt
$ -351.60M$ -1.35B$ -1.35M-$ -11.21B$ -294.00M
Free Cash Flow
$ 2.41B$ 2.99B$ 2.31B$ 2.02B$ 2.03B$ 1.67B
Domestic Sales
------
Foreign Sales
------
Currency in USD

Royalty Pharma Cash Flow

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis